CLINE CHRISTOPHER R. (CHIEF FINANCIAL OFFICER) sold 2.1% of their position (2.49K shares) of TRAVERE THERAPEUTICS, INC. on the open market
Open‑market sale worth $115.4K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 5/7/2026ACC: 0001943192-26-000004
Officer· CHIEF FINANCIAL OFFICER
Since Feb 2026
+6.01K
Net shares
Net buyer
$115.4K
Total sold
2
Open market trades
0B · 2S
5
Total transactions
12.75K acquired · 6.74K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
+4.25K
Price / share
—
Trade value
—
% of position
3.6%
5/4/2026
116.90K→121.15K
Common Stock
Direct
Shares
−2.18K
Price / share
$46.65
Trade value
$101.74K
% of position
1.8%
5/5/2026
121.15K→118.97K
Common Stock
Direct
Shares
−310.00
Price / share
$43.95
Trade value
$13.62K
% of position
0.3%
5/6/2026
118.97K→118.66K
Total
Net shares
+1.76K
Net value
-$115.37K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/4/2026 | M · Option Exercise | +4.25K | — | — | 3.6% | 116.90K | 121.15K |
| Common Stock Direct | 5/5/2026 | S · Sale | −2.18K | $46.65 | $101.74K | 1.8% | 121.15K | 118.97K |
| Common Stock Direct | 5/6/2026 | S · Sale | −310.00 | $43.95 | $13.62K | 0.3% | 118.97K | 118.66K |
| Total | +1.76K | -$115.37K | ||||||
Derivative Transactions2
Performance-based restricted stock units
Direct
Converts to
Common Stock
8.50K shares
Shares
+8.50K
Strike price
Held after
8.50K
Exercisable
—
5/4/2026
Performance-based restricted stock units
Direct
Converts to
Common Stock
4.25K shares
Shares
−4.25K
Strike price
Held after
4.25K
Exercisable
—
5/4/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Performance-based restricted stock units Direct | Common Stock8.50K shares | 5/4/2026 | A · Award | +8.50K | — | 8.50K | |
| Performance-based restricted stock units Direct | Common Stock4.25K shares | 5/4/2026 | M · Option Exercise | −4.25K | — | 4.25K |